Whatever efforts the US FDA may have underway to continue developing a final rule phasing out the distribution of paper labels seem like they are about to come to a halt.
The House Appropriations Committee caught wind of the endeavor and issued a sharp rebuke in the fiscal year 2019...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?